期刊文献+

自拟复方中药联合替吉奥治疗晚期结直肠癌疗效观察 被引量:8

Self-made Compound Chinese Medicine Combined with Gimeracil and Oteracil Porassium Capsules for the Treatment of Advanced Colorectal Cancer
下载PDF
导出
摘要 目的:观察自拟复方中药联合替吉奥治疗晚期结直肠癌的临床疗效及毒副反应。方法:选择晚期结直肠癌术后化疗患者40例,随机分为治疗组和对照组各20例,治疗组采用自拟复方中药联合替吉奥治疗,对照组单纯采用FOLFOX4方案化疗。比较两组患者化疗前后生存质量改善情况、血清肿瘤标记物(CEA、CA19-9、CA72-4)、肿瘤坏死因子-α(TNF-α)及白介素-12(IL-12)含量以及血常规、肝肾功及心电图等相关检查指标的变化情况。结果:经过治疗,治疗组在降低血清肿瘤标记物CEA、CA19-9,优于对照组,且可明显改善患者生存质量,治疗组化疗后TNF-α及IL-12升高,而对照组降低,组间比较差异有统计学意义(P<0.05)。结论:自拟复方中药联合替吉奥对化疗毒副反应具有一定的防治作用,并能降低血清肿瘤标记物水平,同时可以改善患者临床症状和机体一般状况,值得临床推广应用。 Objective: To observe the effect and toxicity of the regimen of Self-made compound chinese medicine combined with chemotherapy scheme of gimeracil and oteracil porassium capsules (S-1) for the treatment of advanced colorectal cancer. Methods : Forty advanced colorectal cancer patients after doing colorectal operation were selected and divided into two groups randomly. The twenty patients in the treat group were treated with Self-made compound chinese medicine combined with gimeracil and oteracil po- rassium capsules (S-1) chemical therapy and the twenty patients in the control group were treated simply with FOLFOX4 chemical therapy. The seriousness of the adverse effects during the chemical therapy,alleviation of clinical symptoms, of serum tumor indica- ting(CEA,CA19-9,CA72-4) , Tumor necrosis factor alpha (TNF -α) and interleukin 12 (IL-12) content,the target of liver and kid- ney function, blood routine, ECG,. were compared and the differences were analysed by statistics. Results:The serum level of CEA, CA19-9, The treatment group can obviously improve the quality of survival, is better than the control group. Levels of TNF-α and IL-12 significantly elevated in the test group after treatment but lowered in the control group, showing significant difference between groups(both P〈 0. 05). Conclusion: Self-made compound chinese medicine combined with oteracil porassium capsules chemical therapy has remarkable therapeutic effect Oil reducing adverse effects,it can reduce serum tumor indicating, and it Can improve clini- cal symptoms and common conditions.
机构地区 沧州市中心医院
出处 《亚太传统医药》 2015年第3期112-114,共3页 Asia-Pacific Traditional Medicine
基金 沧州市科学技术研究与发展指导计划项目(131302183)
关键词 替吉奥 晚期结直肠癌 自拟复方中药 Gimeracil and Oteracil Porassium Capsules (S- 1) Advanced Colorectal Cancer Self-made Compound Chinese Medicine
  • 相关文献

参考文献6

二级参考文献20

  • 1林丽珠,赵永心,郑心婷.中医药治疗对大肠癌患者生存质量的影响[J].肿瘤研究与临床,2008,20(8):516-518. 被引量:3
  • 2江明凤,马彦俊.全身热疗对晚期恶性肿瘤患者肝肾功能的影响[J].检验医学,2007,22(3):354-357. 被引量:3
  • 3吕晓涓,应环珍,陈光义.局部热疗对晚期消化道恶性肿瘤患者免疫功能的影响[J].中国医学文摘(检验与临床),2007,21(4):198-200. 被引量:2
  • 4Ohtsu A,Baba H,Sakata Y,et al.PhaseⅡstudy of S-1,a no-vel oral fluorophyrimidine derivative,in patients with metastaticcolorectal carcinoma.S-1 Cooperative Colorectal Carcinoma StudyGroup[J].Br J Cancer,2000,83:141-145.
  • 5Shirao K,Ohtsu A,Takada H,et al.PhaseⅡstudy of oral S-1for treatment of metastatic colorectal carcinoma[J].Cancer,2004,100:2355-2361.
  • 6Kato T,Shimamoto Y,Uchida J,et al.Possible regulation of 5-fluorouracil-induced neuro-and oral toxicities by two biochemicalmodulators consisting of S-1,a new oral formulation of 5-fluorou-racil[J].Anticancer Res,2001,21:1705-1712.
  • 7Robben NC,Pippas AW,Moore JO.The syndrome of 5-fluorou-racil cardiotoxicity.An elusive cardiopathy[J].Cancer,1993,71:493-509.
  • 8Takechi T,Nakano K,Uchida J,et al.Antitumor activity andlow intestinal toxicity of S-1,a new formulation of oral tegafur,inexperimental tumor models in rats[J].Cancer Chemother Phar-macol,1997,39:205-211.
  • 9Van den Brande J,Schoffski P,Schellens JH,et al.EORTCEarly Clinical Studies Group early phaseⅡtrial of S-1 in patientswith advanced or metastatic colorectal cancer[J].Br J Cancer,2003,88:648-653.
  • 10Saltz LB,Cox JV,Blanke C,et al.Irinotecan plus fluorouraciland leucovorin for metastatic colorectal cancer.Irinotecan StudyGroup[J].N Engl J Med,2000,343:905-914.

共引文献52

同被引文献181

引证文献8

二级引证文献85

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部